Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 105931
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.105931
Table 1 Baseline data and disease composition, n (%)
Variable
Value
n263
Disease
    GC71 (27.00)
    GU88 (33.46)
    CG104 (39.54)
Age, M (Q25, Q75)66.00 (54.00, 74.00)
Sex
    Male164 (62.36)
    Female99 (37.64)
Table 2 Differences in pepsinogen, gastrin-17, carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in different disease states, M (Q25, Q75)

GC (n = 71)
GU (n = 88)
CG (n = 104)
P value
PGI, ng/mL85.71 (48.19, 176.47)a121.37 (75.42, 170.03)96.07 (73.44, 139.51)0.025
PGII, ng/mL18.87 (9.57, 35.14)b15.16 (10.19, 21.58)c8.73 (5.23, 12.66)< 0.001
PGI/PGII ratio5.02 (2.80, 8.13)a,b8.06 (6.18, 9.67)c12.88 (8.99, 17.58)< 0.001
G17, pmol/L8.60 (3.97, 19.82)a,b4.96 (2.41, 9.10)c2.80 (1.33, 5.83)< 0.001
CEA, ng/mL2.02 (1.00, 6.54)a,b0.91 (0.51, 1.77)1.13 (0.80, 1.55)< 0.001
CA19-9, U/mL7.61 (3.75, 22.13)a4.96 (3.50, 8.93)5.36 (3.50, 10.96)0.019
CA72-4, U/mL2.89 (1.19, 11.74)a,b0.65 (0.60, 1.74)0.81 (0.60, 1.67)< 0.001
Table 3 Diagnostic value of pepsinogen, gastrin-17, carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 for gastric ulcer and cancer

Cut-off value
GC (n = 71)
GU (n = 88)
χ2
P value
Sensitivity
Specificity
Youden index
Positive predictive value
Negative predictive value
PGI, ng/mL≥ 169.85521220.4170.5180.2960.750.0460.4880.569
< 169.8555066
PGII, ng/mL≥ 30.55522517.848< 0.0010.310.9430.2530.8150.629
< 30.5554983
PGI/PGII ratio≥ 16.52911120.1090.7410.1550.8640.0190.4780.559
< 16.5296076
G17, pmol/L≥ 6.435473411.9440.0010.6620.6140.2760.580.692
< 6.4352454
CEA, ng/mL≥ 2.005361520.433< 0.0010.5070.830.3370.7060.676
< 2.0053573
CA19-9, U/mL≥ 16.6523715.333< 0.0010.3240.920.2440.7670.628
< 16.654881
CA72-4, U/mL≥ 2.075441828.473< 0.0010.620.7950.4150.710.722
< 2.0752770